Literature DB >> 15749927

A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients.

Rafael Bornstein1, Ana I Flores, M Angeles Montalbán, Manuel J del Rey, Javier de la Serna, Florinda Gilsanz.   

Abstract

Umbilical cord blood transplantation (UCBT) has been used increasingly in both pediatric and adult patients. The total nucleated cell (NC) dose infused is the most critical factor in determining speed of engraftment and survival. Using standard collection techniques, the mean NC content of UCB units is about 10 x 10(8) and only 25% of these units reach the target cell dose of 2 x 10(7)/kg in UCBT patients weighing 50-70 kg. We have designed a modified placental/umbilical two-step collection method in which a standard blood fraction obtained by umbilical venipuncture is combined with a second fraction harvested after placental perfusion with 50 ml heparinized 0.9% saline. This second fraction contributed 32% volume and 15% NCs to the whole UCB unit (123.7 +/- 50.1 ml and 1.26 +/- 0.52 x 10(9) NC). The proportion of progenitor cells in both fractions was not significantly different, indicating that the hematopoietic potential of these larger units is 20% (range, 2%-100%) higher than UCB units collected by standard methods. In addition, the bacterial contamination rate associated with this novel collection method (2.78%) compares favorably. Since 1998 we have further enriched our units by processing only UCB units over 0.8 x 10(9) NCs, resulting in a 36% cell increment (1.46 +/- 0.52 x 10(9) NCs). Thus, 84% and 54% of the Madrid UCB Bank inventory would fulfill the target cell dose of 2 x 10(7)/kg in patients weighing 50 and 65 kg, respectively. This significant UCB banking improvement gives larger pediatric and adult patients a greater chance of finding adequate grafts in order to achieve better clinical outcomes after UCBT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749927     DOI: 10.1634/stemcells.2004-0047

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  11 in total

1.  Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.

Authors:  Xin-Qin Kang; Wei-Jin Zang; Li-Jun Bao; Dong-Ling Li; Tu-Sheng Song; Xiao-Li Xu; Xiao-Jiang Yu
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.

Authors:  Stefan Riedel; Alan Junkins; Paul D Stamper; Gretchen Cress; John A Widness; Gary V Doern
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

3.  Expansion of human hematopoietic stem cells for transplantation: trends and perspectives.

Authors:  Hera Andrade-Zaldívar; Leticia Santos; Antonio De León Rodríguez
Journal:  Cytotechnology       Date:  2008-03-29       Impact factor: 2.058

4.  Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation.

Authors:  C Basford; N Forraz; S Habibollah; K Hanger; C P McGuckin
Journal:  Cell Prolif       Date:  2009-09-15       Impact factor: 6.831

Review 5.  Ex vivo expansion of umbilical cord blood: where are we?

Authors:  Omar S Aljitawi
Journal:  Int J Hematol       Date:  2012-03-23       Impact factor: 2.490

6.  Monitoring adenoviral based gene delivery in rat glioma by molecular imaging.

Authors:  Nadimpalli Ravi S Varma; Kenneth N Barton; Branislava Janic; Adarsh Shankar; Asm Iskander; Meser M Ali; Ali S Arbab
Journal:  World J Clin Oncol       Date:  2013-11-10

7.  Hematopoietic stem cell expansion facilitates multilineage engraftment in a nonhuman primate cord blood transplantation model.

Authors:  Korashon L Watts; Veronica Nelson; Brent L Wood; Grant D Trobridge; Brian C Beard; R Keith Humphries; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2011-12-08       Impact factor: 3.084

8.  Pkb/Akt1 mediates Wnt/GSK3β/β-catenin signaling-induced apoptosis in human cord blood stem cells exposed to organophosphate pesticide monocrotophos.

Authors:  Mahendra P Kashyap; Abhishek K Singh; Vivek Kumar; Dharmendra K Yadav; Feroz Khan; Sadaf Jahan; Vinay K Khanna; Sanjay Yadav; Aditya B Pant
Journal:  Stem Cells Dev       Date:  2012-08-16       Impact factor: 3.272

9.  Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major.

Authors:  Sandip A Shah; Kamlesh M Shah; Kinnari A Patel; Asha S Anand; Shailesh S Talati; Harsha P Panchal; Apurva A Patel; Sonia K Parikh; Bhavesh B Parekh; Shilin N Shukla; Shreeniwas S Raut
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-19       Impact factor: 0.900

Review 10.  Umbilical cord transplantation: epilogue.

Authors:  Hal E Broxmeyer
Journal:  Semin Hematol       Date:  2010-01       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.